BRAF
17.04.2024
Paradox-Breaker BRAF inhibitor plixorafenib (FORE8394) synergizes with MEKi in BRAF V600 and non- V600 alterations
Read more
BRAF
17.04.2024
Dose optimization of novel BRAF inhibitor FORE8394 based on PK and efficacy results
Read more
BRAF
17.04.2024
Efficacy of BRAF Inhibitor Plixorafenib (FORE8394) in Recurrent PCNST
Read more
BRAF
17.04.2024
Safety & Efficacy of BRAF Inhibitor FORE8394 Patients w. Advanced Solid & CNS Tumors
Read more
BRAF
13.09.2022
Efficacy of BRAF Inhibitor FORE8394 in BRAF V600+ Patients
Read more
BRAF
20.05.2021
AACR Virtual Annual Meeting I: Insights Gained from AACR Project GENIE
Read more
BRAF
15.08.2020
A systematic analysis of BRAF mutations and their sensitivity to different BRAF inhibitors
Read more
BRAF
06.03.2020
A Novel System for Functional Determination of Variants of Uncertain Significance using Deep Convolutional Neural Networks
Read more
BRAF
21.02.2018
Revisited analysis of a SHIVA01 trial cohort using functional mutational analyses successfully predicted treatment outcome
Read more
BRAF
11.10.2016
Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation
Read more